trending Market Intelligence /marketintelligence/en/news-insights/trending/veocshwjcd0ty12rbrgc-w2 content esgSubNav
In This List

Warburg Pincus, CNCB lead investment round for Jinxin Fertility

Blog

Post-webinar Q&A: Speed and Scalability – Automation in Credit Risk Modeling

Case Study

A Chinese Bank Takes Steps to Minimize Risks as it Supports International Trade

Blog

Middle East Africa MA by the Numbers: Q3 2021

Blog

Banking Essentials Newsletter: November Edition 2021 - Part 2


Warburg Pincus, CNCB lead investment round for Jinxin Fertility

Jinxin Fertility obtained an undisclosed strategic investment from a group of backers led by Warburg Pincus Asia LLC and CNCB (Hong Kong) Investment Co. Ltd., China Money Network reported, citing a statement from Warburg Pincus.

Venture capital firm Sequoia Capital China and Shanghai-based biotechnology company WuXi AppTec Co. Ltd. also participated.

Following the transaction, Warburg Pincus and CNCB will be the second- and third-largest shareholders, respectively, of Jinxin, the news outlet noted.

The Chinese assisted reproductive technology company is part of hospital developer and operator Chengdu Jinxin Healthcare Investment Management Group Ltd.